Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arne Reimers

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Open Access Journal of Contraception|February 2, 2018
Contraception for women with epilepsy: counseling, choices, and concernsArne Reimers
Bipolar Disorders|March 29, 2019
Lamotrigine, bipolar disorder, and the pill-free weekArne Reimers
Expert Opinion on Pharmacotherapy|August 13, 2024
Pharmacotherapy for focal epilepsy: how close are we to a cure?Arne Reimers
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|July 2, 2004
[Oral contraceptives can affect the metabolism of other drugs]Arne Reimers
Seizure|June 9, 2014
New antiepileptic drugs and womenArne Reimers
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 6, 2017
Arne Reimers
Pharmacoepidemiology and Drug Safety|December 18, 2008
Trends and changes in the clinical use of lamotrigineArne Reimers
Epilepsia|November 3, 2016
Hormone replacement therapy with estrogens may reduce lamotrigine serum concentrations: A matched case-control studyArne Reimers
Drug Safety|October 30, 2003
Declaration of fructose and fructose-related adverse effects in commercial drug preparations in European countriesArne Reimers, Olav Spigset
Expert Opinion on Pharmacotherapy|March 26, 2019
An evaluation of zonisamide, including its long-term efficacy, for the treatment of focal epilepsyArne Reimers, Hanna Ljung
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Open Access Journal of Contraception|February 2, 2018
Contraception for women with epilepsy: counseling, choices, and concernsArne Reimers
Bipolar Disorders|March 29, 2019
Lamotrigine, bipolar disorder, and the pill-free weekArne Reimers
Expert Opinion on Pharmacotherapy|August 13, 2024
Pharmacotherapy for focal epilepsy: how close are we to a cure?Arne Reimers
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|July 2, 2004
[Oral contraceptives can affect the metabolism of other drugs]Arne Reimers
Seizure|June 9, 2014
New antiepileptic drugs and womenArne Reimers
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 6, 2017
Arne Reimers
Pharmacoepidemiology and Drug Safety|December 18, 2008
Trends and changes in the clinical use of lamotrigineArne Reimers
Epilepsia|November 3, 2016
Hormone replacement therapy with estrogens may reduce lamotrigine serum concentrations: A matched case-control studyArne Reimers
Drug Safety|October 30, 2003
Declaration of fructose and fructose-related adverse effects in commercial drug preparations in European countriesArne Reimers, Olav Spigset
Expert Opinion on Pharmacotherapy|March 26, 2019
An evaluation of zonisamide, including its long-term efficacy, for the treatment of focal epilepsyArne Reimers, Hanna Ljung
Pageof 6